{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:40:09Z","timestamp":1786866009696,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA83178"],"award-info":[{"award-number":["U01 CA83178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA97397"],"award-info":[{"award-number":["R01 CA97397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA129639"],"award-info":[{"award-number":["R01 CA129639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA114236"],"award-info":[{"award-number":["R01 CA114236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA168339"],"award-info":[{"award-number":["R01 CA168339"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-0948-4","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:26:40Z","timestamp":1522816000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study"],"prefix":"10.1186","volume":"20","author":[{"name":"WECARE Study Collaborative Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Blackmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonine L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1159\u201369.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J. Cancer. 2015;136:E359\u2013E86.","journal-title":"Int J. Cancer."},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canep.2012.02.007","volume":"36","author":"DR Youlden","year":"2012","unstructured":"Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237\u201348.","journal-title":"Cancer Epidemiol."},{"key":"948_CR4","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomark Prev. 1999;8:855\u201361.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34:611\u201335.","journal-title":"J Clin Oncol."},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/jnci\/djh260","volume":"96","author":"LA Habel","year":"2004","unstructured":"Habel LA, Dignam JJ, Land SR, Salane M, Capra AM, Julian TB. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004;96:1467\u201372.","journal-title":"J Natl Cancer Inst."},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/1055-9965.EPI-07-0458","volume":"16","author":"ES Hwang","year":"2007","unstructured":"Hwang ES, Miglioretti DL. Ballard-Barbash R, Weaver DL, Kerlikowske K for the National Cancer Institute Breast Cancer Surveillance Consortium. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2007;16:2587\u201393.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1055-9965.EPI-10-0769","volume":"19","author":"LA Habel","year":"2010","unstructured":"Habel LA, Capra AM, Achacoso NS, Janga A, Acton L, Puligandla B, et al. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2010;19:2488\u201395.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10549-010-1106-6","volume":"124","author":"DSM Buist","year":"2010","unstructured":"Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124:863\u201373.","journal-title":"Breast Cancer Res Treat."},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10549-016-4039-x","volume":"161","author":"M Chowdhury","year":"2017","unstructured":"Chowdhury M, Euhus D, Onega T, Biswas S, Choudhary PK. A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat. 2017;161:153\u201360.","journal-title":"Breast Cancer Res Treat."},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/cncr.30573","volume":"123","author":"A Raghavendra","year":"2017","unstructured":"Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M Jr, et al. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer. 2017;123:1935\u201340.","journal-title":"Cancer."},{"key":"948_CR12","first-page":"R57","volume":"15","author":"ME Sandberg","year":"2013","unstructured":"Sandberg ME, Li J, Hall P. Hartman M, dos-Santos-Silva I. Humphreys K et al Change of mammographic density predicts the risk of contralateral breast cancer \u2013 a case-control study Breast Cancer Res. 2013;15:R57.","journal-title":"Humphreys K et al Change of mammographic density predicts the risk of contralateral breast cancer \u2013 a case-control study Breast Cancer Res."},{"key":"948_CR13","doi-asserted-by":"crossref","unstructured":"Lienhart V, Carly B, Kang X, Guzy L, Sajovitz A-M, Liebens F. Effect of preventive hormonal therapy on breast density: a systematic qualitative review. Scientific World J. 2014;2014. Article ID 942386.","DOI":"10.1155\/2014\/942386"},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.18632\/oncotarget.13484","volume":"8","author":"MS Shawky","year":"2017","unstructured":"Shawky MS, Martin H, Hugo HJ, Lloyd T, Britt KL, Redfern A, et al. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies. Oncotarget. 2017;8:5578\u201391.","journal-title":"Oncotarget."},{"key":"948_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1148\/radiol.09091090","volume":"255","author":"J-H Chen","year":"2010","unstructured":"Chen J-H, Nie K, Bahri S, Hsu C-C, Hsu F-T, Shih H-N, et al. Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology. 2010;255:44\u201352.","journal-title":"Radiology."},{"key":"948_CR16","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1088\/0031-9155\/39\/10\/008","volume":"39","author":"JW Byng","year":"1994","unstructured":"Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39:1629\u201338.","journal-title":"Phys Med Biol."},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.amjsurg.2013.08.002","volume":"206","author":"IM Lizarraga","year":"2013","unstructured":"Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CEH. Review of risk factors for the development of contralateral breast cancer. Am J Surg. 2013;206:704\u20138.","journal-title":"Am J Surg."},{"key":"948_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrclinonc.2014.3","volume":"11","author":"SA Narod","year":"2014","unstructured":"Narod SA. Bilateral breast cancers. Nat Rev Clin Oncol. 2014;11:157\u201366.","journal-title":"Nat Rev Clin Oncol."},{"key":"948_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/bcr1829","volume":"9","author":"CM Vachon","year":"2007","unstructured":"Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt K, et al. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007;9:217.","journal-title":"Breast Cancer Res."},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","volume":"148","author":"JA Tice","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148:337\u201347.","journal-title":"Ann Intern Med."},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/1055-9965.EPI-14-1136","volume":"24","author":"KA Bertrand","year":"2015","unstructured":"Bertrand KA, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Norman AD, et al. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomark Prev. 2015;24:798\u2013809.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"948_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2015.64.4492","volume":"34","author":"M Mullooly","year":"2016","unstructured":"Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, et al. Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications. J Clin Oncol. 2016;34:2093\u20137.","journal-title":"J Clin Oncol."},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/1055-9965.EPI-15-0412","volume":"25","author":"SJ Nyante","year":"2016","unstructured":"Nyante SJ, Sherman ME, Pfeiffer RM, de Gonzalez AB, Brinton LA, Bowles EJA, et al. Longitudinal change in mammographic density among ER-positive breast cancer patients using tamoxifen. Cancer Epidemiol Biomark Prev. 2016;25:212\u20136.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13058-014-0439-1","volume":"16","author":"A Eng","year":"2014","unstructured":"Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, et al. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014;16:439.","journal-title":"Breast Cancer Res."},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13058-016-0715-3","volume":"18","author":"LA Habel","year":"2016","unstructured":"Habel LA, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, et al. Case-control study of mammographic density and breast cancer risk using processed digital mammograms. Breast Cancer Res. 2016;18:53.","journal-title":"Breast Cancer Res."},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13058-016-0756-7","volume":"18","author":"MC Busana","year":"2016","unstructured":"Busana MC, Eng A, Denholm R, Dowsett M, Vinnicombe S, Allen S, et al. Impact of type of full-field digital image on mammographic density assessment and breast cancer risk estimation: a case-control study. Breast Cancer Res. 2016;18:96.","journal-title":"Breast Cancer Res."},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamaoncol.2016.3340","volume":"3","author":"GL Gierach","year":"2017","unstructured":"Gierach GL, Curtis RE, Pfeiffer RM, Mullooly M, Ntowe EA, Hoover RN, et al. Association of adjuvant tamoxifen and aromatase inhibitor therapy with contralateral breast cancer risk among US women with breast cancer in a general community setting. JAMA Oncol. 2017;3:186\u201393.","journal-title":"JAMA Oncol."},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1604700","volume":"375","author":"PE Goss","year":"2016","unstructured":"Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med. 2016;375:209\u201319.","journal-title":"N Engl J Med."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-0948-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:35:34Z","timestamp":1589549734000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-0948-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-0948-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study participants provided written informed consent and the study was approved by local Institutional Review or Research Ethics Boards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}